Available at research and GMP grade to intensify production of recombinant AAV rAAV viral vectors at any scale from benchtop to 2000L scale bioreactor...
Meet our team during JSGCT, The Japanese Society for Gene and Cell Therapy in Osaka, Japan, September 10th -13th 2023. We will be presenting our infographic on Polyplus® solutions for viral vector production.
Infographic: Polyplus solutions for viral vector production
Polyplus (now part of Sartorius) is a key supplier of critical raw materials for cell and gene therapy manufacturing process. The production of viral vectors such as AAV and LV requires two major components in the upstream process: plasmid DNA and transfection reagent. Polyplus provides solutions for plasmid engineering, manufacturing and transfection together with a free scientific support service to support customers optimizing their upstream process.